The Company announced the appointment of new members to its Board of Directors to help guide its next phase of growth and innovation, including ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

And welcome to the Vertex Pharmaceuticals Third Quarter 2024 Earnings ... so I think that you’re getting plenty of drug on board and you’ve already had some pretty good results.

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Vertex's success has been achieved largely on the back of its cystic fibrosis (CF) drugs. The company remains the only provider of therapies that treat the underlying genetic cause of the rare genetic ...

ROCKVILLE, Md. & EDMONTON, Alberta, November 07, 2024--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it has appointed Craig Johnson to its ...

Faron's Shareholders' Nomination Board consists of three members, which represent the Company's shareholders. The Chair of Faron's Board of Directors ... About Faron Pharmaceuticals Ltd Faron (AIM: ...

Investment fund Oaktree Capital Management has urged British drugmaker Indivior (INDV.L), opens new tab to cooperate with the fund in refreshing its board of directors, it said in a letter dated ...

October 29, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the Company’s board of directors has determined that an unsolicited and non ...